Literature DB >> 8211662

Stereotaxic radiosurgical ablation: an alternative treatment for recurrent and multifocal hemangioblastomas. A report of four cases.

K A Page1, K Wayson, G K Steinberg, J R Adler.   

Abstract

Craniotomy and resection is usually a safe and effective treatment for hemangioblastoma. However, since the surgical removal of recurrent and multifocal tumors can be associated with greater risks, stereotaxic radiosurgery was used to ablate hemangioblastomas in four patients with von Hippel-Lindau disease. In two of these cases a symptomatic lesion was surgically resected just prior to radiosurgery. The 11 radiosurgically treated tumors (four patients) were spherical and varied in diameter from 0.75 to 2.0 cm with a mean of 1.25 cm. Dose ranged from 30 to 75 Gy with a mean of 35 Gy. After a mean clinical and radiologic follow-up of greater than 1 1/2 years, tumor size and/or cyst formation was controlled in all cases. Nevertheless, it was necessary to temporarily shunt a tumor cyst in one patient. In another case, aggressive treatment resulted in symptomatic radiation necrosis. Despite such potential problems we believe that radiosurgical tumor ablation is a reasonable alternative to craniotomy and/or radiation therapy in poor risk patients. This report is believed to be the first published description of the use of radiosurgery in the treatment of hemangioblastoma.

Entities:  

Mesh:

Year:  1993        PMID: 8211662     DOI: 10.1016/0090-3019(93)90225-p

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  6 in total

1.  Stereotactic radiosurgery for central nervous system hemangioblastoma: systematic review and meta-analysis.

Authors:  James Pan; Rashad Jabarkheel; Yuhao Huang; Allen Ho; Steven D Chang
Journal:  J Neurooncol       Date:  2017-12-04       Impact factor: 4.130

2.  Cerebellar haemangioblastoma: temporising treatment in a high risk pregnancy.

Authors:  Tausif Rehman; Rushna Ali; Howard Yonas
Journal:  BMJ Case Rep       Date:  2009-05-21

3.  Prospective evaluation of radiosurgery for hemangioblastomas in von Hippel-Lindau disease.

Authors:  Ashok R Asthagiri; Gautam U Mehta; Leor Zach; Xiaobai Li; John A Butman; Kevin A Camphausen; Russell R Lonser
Journal:  Neuro Oncol       Date:  2009-12-23       Impact factor: 12.300

4.  Treatment of recurrent cerebellar hemangioblastoma with external radiotherapy in a patient with von Hippel-Lindau disease: a case report and review of the literature.

Authors:  Gulcin Ertas; Muzaffer Bedri Altundag; Ali Riza Ucer; Fatih Cankal; Kadri Altundag
Journal:  J Neurooncol       Date:  2005-07       Impact factor: 4.130

5.  The clinical outcome of intracranial hemangioblastomas treated with linac-based stereotactic radiosurgery and radiotherapy.

Authors:  Putipun Puataweepong; Mantana Dhanachai; Ake Hansasuta; Somjai Dangprasert; Chomporn Sitathanee; Parmon Puddhikarant; Chuleeporn Jiarpinitnun; Rawee Ruangkanchanasetr; Patchareporn Dechsupa; Kumutinee Pairat
Journal:  J Radiat Res       Date:  2014-02-18       Impact factor: 2.724

6.  Stereotactic radiosurgery in hemangioblastoma: Experience over 14 years.

Authors:  Nishant Goyal; Deepak Agrawal; Raghav Singla; Shashank Sharad Kale; Manmohan Singh; Bhawani Shankar Sharma
Journal:  J Neurosci Rural Pract       Date:  2016 Jan-Mar
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.